Terms: = Bone cancer AND B2M, P61769, 567, ENSG00000166710 AND Prognosis
12 results:
1. Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis.
Ivanova VS; Davies J; Menter T; Wild D; Müller A; Krasniqi F; Stenner F; Papachristofilou A; Dirnhofer S; Tzankov A
Histopathology; 2024 Feb; 84(3):525-538. PubMed ID: 37965677
[TBL] [Abstract] [Full Text] [Related]
2. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia.
Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P
Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330
[TBL] [Abstract] [Full Text] [Related]
3. Frequent mutated b2m, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.
de Groen RAL; van Eijk R; Böhringer S; van Wezel T; Raghoo R; Ruano D; Jansen PM; Briaire-de Bruijn I; de Groot FA; Kleiverda K; Te Boome L; Terpstra V; Levenga H; Nicolae A; Posthuma EFM; Focke-Snieders I; Hardi L; den Hartog WCE; Bohmer LH; Hogendoorn PCW; van den Berg A; Diepstra A; Nijland M; Lugtenburg PJ; Kersten MJ; Pals ST; Veelken H; Bovée JVMG; Cleven AHG; Vermaat JSP
Blood Adv; 2021 Oct; 5(19):3760-3775. PubMed ID: 34478526
[TBL] [Abstract] [Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT.
Esteve J; Giebel S; Labopin M; Czerw T; Wu D; Volin L; Socié G; Yakoub-Agha I; Maertens J; Cornelissen JJ; Pigneux A; Shimoni A; Schwerdtfeger R; Labussière-Wallet H; Russell N; Schattenberg A; Chevallier P; Koza V; Foà R; Schmid C; Peric Z; Mohty M; Nagler A
Leukemia; 2021 Aug; 35(8):2232-2242. PubMed ID: 33542481
[TBL] [Abstract] [Full Text] [Related]
5. iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells.
Fu D; Liu S; Liu J; Chen W; Long X; Chen X; Zhou Y; Zheng Y; Huang S
J Clin Lab Anal; 2021 Mar; 35(3):e23653. PubMed ID: 33405298
[TBL] [Abstract] [Full Text] [Related]
6. Survival in breast cancer patients with spine metastases: Prognostic assessment involving molecular markers.
Amelot A; Terrier LM; Cristini J; Buffenoir K; Pascal-Moussellard H; Carpentier A; Bonaccorsi R; Le Nail LR; Mathon B
Eur J Surg Oncol; 2020 Jun; 46(6):1021-1027. PubMed ID: 31899046
[TBL] [Abstract] [Full Text] [Related]
7. Relationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas.
Wang B; Yao H; Xie X; Yin J; Zou C; Huang G; Shen J
Cancer Chemother Pharmacol; 2018 Aug; 82(2):221-227. PubMed ID: 29808416
[TBL] [Abstract] [Full Text] [Related]
8. Exploring the Clinicopathological Parameters Affecting the Outcome in Egyptian Patients with Multiple Myeloma.
Sallam YA; Samra MA; Gaber AA
Gulf J Oncolog; 2016 Jan; 1(20):51-63. PubMed ID: 27050180
[TBL] [Abstract] [Full Text] [Related]
9. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.
Jeon DG; Kong CB; Cho WH; Song WS; Cho SH; Choi SW; Lee SY
J Surg Oncol; 2014 Mar; 109(3):275-9. PubMed ID: 24243222
[TBL] [Abstract] [Full Text] [Related]
10. Sinonasal melanoma: survival and prognostic implications based on site of involvement.
Khan MN; Kanumuri VV; Raikundalia MD; Vazquez A; Govindaraj S; Baredes S; Eloy JA
Int Forum Allergy Rhinol; 2014 Feb; 4(2):151-5. PubMed ID: 24190249
[TBL] [Abstract] [Full Text] [Related]
11. Do baseline Cereblon gene expression and IL-6 receptor expression determine the response to thalidomide-dexamethasone treatment in multiple myeloma patients?
Bedewy AM; El-Maghraby SM
Eur J Haematol; 2014 Jan; 92(1):13-8. PubMed ID: 24118365
[TBL] [Abstract] [Full Text] [Related]
12. Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients.
García-Sanz R; González-Fraile MI; Mateo G; Hernández JM; López-Berges MC; de las Heras N; Fernández-Calvo J; Ortega F; Portero JA; Bárez A; Galende J; Orfão A; San Miguel JF
Int J Cancer; 2004 Dec; 112(5):884-9. PubMed ID: 15386370
[TBL] [Abstract] [Full Text] [Related]
